StockNews.com Initiates Coverage on Chimerix (NASDAQ:CMRX)
Analysts at StockNews.com began coverage on shares of Chimerix (NASDAQ:CMRX – Get Free Report) in a research report issued to clients and investors on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. A number of other equities research analysts have also recently weighed in on the company. Jefferies Financial Group reiterated […]
Analysts at StockNews.com began coverage on shares of Chimerix (NASDAQ:CMRX – Get Free Report) in a research report issued to clients and investors on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. A number of other equities research analysts have also recently weighed in on the company. Jefferies Financial Group reiterated […]